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CASE PRESENTATION
A 34-year-old female with a history of methamphetamineassociated cardiomyopathy presented to the emergency department (ED) with generalized weakness, altered mental status, and chest pain. She reported a recent placement of an automatic implantable cardioverter-defibrillator at an outside hospital three months prior to current presentation and had a documented ejection fraction of 15%. Upon arrival to the ED, she was hypotensive with a systolic blood pressure ranging in the 40s to 70s millimeters of mercury and was hypothermic at 33.6 degrees Celsius. She appeared cachectic and had a 3/6 systolic ejection murmur at the left upper sternal border. We performed a point-of-care ultrasound (POCUS) to assess the patient's cardiac function and found a large left ventricular (LV) thrombus measuring 5.8 x 2.8 centimeters (Image). Further views of the thrombus seen in the video reveal a large hyperechoic density in the left ventricle. The patient was admitted to the intensive care unit for vasopressor support and thrombolytic therapy.
DISCUSSION
Cardiovascular disease is the leading cause of death in patients with methamphetamine use, and cardiomyopathy is a rare complication that can occur. 1 This can lead to systolic dysfunction and reduced ejection fraction, which is an important risk factor for the formation of LV thrombi. 2 In patients with methamphetamine-associated cardiomyopathy with an ejection fraction less than 40%, up to 33% can develop a LV thrombus. 3 POCUS can be used to help diagnose patients with an LV thrombus. 4 Patients found to have a thrombus should be started on anticoagulation therapy. Volume III, no. 
